A Paradigm Shift in Clinical Trial is Occurring

At the Global Genes Patient and Advocacy Summit, Rare Disease Report spoke with Kent Thoelke of PRA Health Sciences about how clinical trial organizations are changing the way patients are being involved in clinical trials.
​​​​​​​
As Thoelke explains, there is a paradigm shift in the way that the clinical trial community is starting to engage with patients.

Orphan Drugs,Rare Disease,